Open access
Sep 2026
TRIM2 suppresses prostate cancer progression by promoting ubiquitin-mediated degradation of DTNBP1
The findings establish the TRIM2-DTNBP1 axis as a key driver of PCa progression and position TRIM2 as a promising prognostic biomarker and a potential predictive indicator for guiding molecularly targeted therapies in advanced PCa.
Jiang He, Sheng Liu, Wei Tong et al.
· Frontiers in Molecular Biosc... · 0 citations